Papillomavirus Infections

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2012-03-22
Clinical Trial Update: Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females [Phase 2]
Phase 2 trial assessing safety and immunogenicity of Cervarix (HPV vaccine) in HIV-infected females has completed with results posted.
CLINICAL_TRIALS trial_result · 2011-05-02
Clinical Trial Update: Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects [Phase 3]
Phase 3 trial update on long-term immunogenicity and safety of an HPV vaccine in healthy females with completed status and posted results.
CLINICAL_TRIALS trial_result · 2010-08-06
Clinical Trial Update: Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18 [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of HPV-16/18 vaccine in young and adult women; study completed with results posted in 201…
CLINICAL_TRIALS trial_result · 2010-07-09
Clinical Trial Update: An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) [Phase 3]
This is a completed Phase 3 clinical trial update evaluating the immunogenicity and safety of Gardasil in Chinese subjects.
CLINICAL_TRIALS trial_result · 2010-01-06
Clinical Trial Update: Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects [Phase 3]
A Phase 3 trial evaluating safety and immunogenicity when co-administering HPV vaccine with another vaccine in healthy female subjects has c…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2009-12-16
Clinical Trial Update: Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine [Phase 2]
Phase 2 trial assessing safety, immunogenicity, and efficacy of Cervarix HPV-16/18 vaccine in adult Japanese women; results posted.
CLINICAL_TRIALS trial_result · 2009-04-14
Clinical Trial Update: Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029) [Phase 3]
Phase 3 trial update on safety, tolerability, and immunogenicity of an HPV vaccine in healthy girls aged 9 to 15; results completed with pos…